Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Corp. buy Wolfe Research

Start price
€890.10
03.12.25 / 50%
Target price
€1,074.1
03.12.26
Performance (%)
-2.55%
Price
€867.40
05.12.25
Summary
This prediction is currently active. With a performance of -2.55%, the BUY prediction by Wolfe_Research is trending in the wrong direction. This prediction currently runs until 03.12.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this prediction
Performance without dividends (%)
Name 1w
Eli Lilly Corp. -2.55%
iShares Core DAX® 0.760%
iShares Nasdaq 100 0.732%
iShares Nikkei 225® 1.025%
iShares S&P 500 -0.036%

Comments by Wolfe_Research for this prediction

In the thread Eli Lilly Corp. diskutieren
Prediction Buy
Perf. (%) -2.55%
Target price 1074.125
Change
Ends at 03.12.26

Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at Wolfe Research from $1,050.00 to $1,250.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat

Stopped prediction by Wolfe_Research for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€732.30
15.11.24
€946.80
15.11.25
20.70%
16.11.25